Cited 12 times in
Clinical significance of anti-annexin V antibody in acute cerebral ischemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김원주 | - |
dc.contributor.author | 이경열 | - |
dc.contributor.author | 허지회 | - |
dc.date.accessioned | 2014-12-20T16:36:55Z | - |
dc.date.available | 2014-12-20T16:36:55Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0022-510X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/93050 | - |
dc.description.abstract | BACKGROUND: Antiphospholipid antibodies (aPLs) are associated with vascular occlusive events. Lupus anticoagulant (LA) and anticardiolipin antibody (aCL) are two aPLs commonly used for screening test. However, other aPLs are reported to play a role in the thrombotic events in other disorders, especially autoimmune disease. We investigated the clinical significance of the anti-annexin V antibody (aAV) in patients with acute cerebral ischemia; annexin V promotes anticoagulant activity via inhibition of prothrombin activation. METHODS: A total of 187 patients with acute cerebral infarction or transient ischemic attack, and 66 control subjects were included in this prospective study. IgG type aAV was determined by enzyme-linked immunosorbent sandwich assay in the patient and control groups. The presence of LA and aCL were determined in the patient group using the usual screening method. RESULTS: IgG aAV was detected in 26 of the 187 patients (13.9%), but only in three of the 66 control subjects (4.5%; P=0.043). Among the 26 aAV positive patients, only five patients were positive for LA or aCL. The presence of IgG aAV was significantly associated with acute cerebral ischemia: one stroke event (OR, 4.39; 95% CI, 1.21-16.01), and two or more stroke events (OR, 3.91; 95% CI, 1.09-14.07). CONCLUSION: IgG aAV was detected in a significant percentage of the patients with acute cerebral ischemia compared with the control group. The presence of IgG aAV did not usually coincide with LA or aCL. Thus aAV should be considered as a possible associated factor for acute cerebral ischemia. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 53~56 | - |
dc.relation.isPartOf | JOURNAL OF THE NEUROLOGICAL SCIENCES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Acute Disease | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Annexin A5/immunology* | - |
dc.subject.MESH | Autoantibodies/blood* | - |
dc.subject.MESH | Blood Coagulation/immunology | - |
dc.subject.MESH | Brain Ischemia/blood | - |
dc.subject.MESH | Brain Ischemia/diagnosis | - |
dc.subject.MESH | Brain Ischemia/immunology* | - |
dc.subject.MESH | Cerebral Infarction/blood | - |
dc.subject.MESH | Cerebral Infarction/immunology | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunoglobulin G/blood | - |
dc.subject.MESH | Immunoglobulin G/physiology | - |
dc.subject.MESH | Intracranial Thrombosis/blood | - |
dc.subject.MESH | Intracranial Thrombosis/immunology | - |
dc.subject.MESH | Ischemic Attack, Transient/blood | - |
dc.subject.MESH | Ischemic Attack, Transient/immunology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Predictive Value of Tests | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Prothrombin/antagonists & inhibitors | - |
dc.subject.MESH | Prothrombin/metabolism | - |
dc.subject.MESH | Stroke/blood | - |
dc.subject.MESH | Stroke/etiology | - |
dc.subject.MESH | Stroke/immunology | - |
dc.title | Clinical significance of anti-annexin V antibody in acute cerebral ischemia | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurology (신경과학) | - |
dc.contributor.googleauthor | Kee Ook Lee | - |
dc.contributor.googleauthor | Won Joo Kim | - |
dc.contributor.googleauthor | Sang-Jun Na | - |
dc.contributor.googleauthor | Ji Hoe Heo | - |
dc.contributor.googleauthor | Kyung-Yul Lee | - |
dc.identifier.doi | 10.1016/j.jns.2011.03.017 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00771 | - |
dc.contributor.localId | A02648 | - |
dc.contributor.localId | A04369 | - |
dc.relation.journalcode | J01897 | - |
dc.identifier.eissn | 1878-5883 | - |
dc.identifier.pmid | 21450308 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0022510X11001274 | - |
dc.subject.keyword | Antiphospholipid antibody | - |
dc.subject.keyword | Anti-annexin V antibody | - |
dc.subject.keyword | Acute cerebral ischemia | - |
dc.subject.keyword | Anticoagulant activity | - |
dc.subject.keyword | Associated factor | - |
dc.subject.keyword | Clinical significance | - |
dc.contributor.alternativeName | Kim, Won Joo | - |
dc.contributor.alternativeName | Lee, Kyung Yul | - |
dc.contributor.alternativeName | Heo, Ji Hoe | - |
dc.contributor.affiliatedAuthor | Kim, Won Joo | - |
dc.contributor.affiliatedAuthor | Lee, Kyung Yul | - |
dc.contributor.affiliatedAuthor | Heo, Ji Hoe | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 305 | - |
dc.citation.number | 1-2 | - |
dc.citation.startPage | 53 | - |
dc.citation.endPage | 56 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE NEUROLOGICAL SCIENCES, Vol.305(1-2) : 53-56, 2011 | - |
dc.identifier.rimsid | 27996 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.